USE OF IMMUNE MODULATORS FOR MAKING MEDICAMENTS OT INHIBIT IMMUNE RESPONSES AGAINST CO-ADMINISTERED RECOMBINANT VIRUSES

摘要

A method of reducing immune response during gene therapy is provided which involves co-administration of the viral vector bearing a therapeutic transgene and a selected immune modulator capable of inhibiting the formation of neutralizing antibodies and/or CTL elimination of the vectors upon repeated administration.